• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV
Click for more information
0.39% $15.63

CLINUVEL PHARMACEUTICALS LIMITED - News & Media

Market Cap $782.1M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
$15.63 		Change
0.060(0.39%) 		Mkt cap ! $782.1M
Open High Low Value Volume
$15.60 $15.67 $15.49 $362.3K 23.24K

Buyers (Bids)

No. Vol. Price($)
1 6 $17.19
 

Sellers (Offers)

Price($) Vol. No.
$14.81 24 2
View Market Depth
Last trade - 15.59pm 27/05/2024 (20 minute delay) ?
Last
$15.63 		  Change
0.060 ( 0.26 %)
Open High Low Volume
$15.63 $15.67 $15.49 2293
Last updated 15.59pm 27/05/2024 ?
CUV (ASX) Chart

Top Stories

Elsight's Halo shines on take off in the Land of the Rising Sun

Elsight’s Halo (ASX:ELS) has been selected by ACSL, Japan’s largest drone manufacturer, as the Beyond Vision Line Of Sight (BVLOS) Communications platform for its drones.Elsight announced today that ACSL had chosen Halo, in conjunction with new Japanese regional pa...
Beamtree score $3.6M contract to expand hospital technology into Saudi Arabia Beamtree Holdings Ltd has achieved a $3.6 million contract which will see it expand its AI technology into hospitals in Saudi Arabia.
Critical minerals bounty in Angola points to prospect extension for Tyranna Tyranna Resources Ltd has picked up high grades in lithium, tantalum and caesium based on drilling at its Muvero prospect in Angola.
Market Update: ASX turns green with real estate flowering The ASX200 is trading up around 0.7 per cent.Most sectors are in the green, real estate has gained the most so far, up nearly 1.6%. Staples follows, up 1.2%.The utilities and energy sectors are the only two to slip into the red.Company newsReal estate company, Lendlease (ASX:LLC) is up nearly 10%...
Elixir reports rise of 328% in contingent resources at QLD gas project Elixir Energy Ltd has reported an upgrade of 328% in its contingent resources at Queensland's Grandis Gas Project.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.